ArticleJournal of the American Heart Association2022

Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study.

Julie Rouette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.